Peripheral vascular technologies are evolving rapidly—from drug-coated balloons to embolic devices. But progress depends on reliable, clinically relevant preclinical testing. Pharmaron delivers precision testing for: > Aneurysm creation and repair > Atherectomy systems > Drug-coated balloon performance > Embolic occlusion devices With validated in vivo models and regulatory-aligned protocols, we help bring effective vascular solutions to patients faster. Explore how we support innovation in peripheral vascular therapies: https://lnkd.in/dmwPqq-E #Pharmaron #PeripheralVascular #PreclinicalTesting #MedicalDevices #VascularInnovation
关于我们
Pharmaron: Global Life Sciences Services Provider Stock Code: 300759.SZ/3759.HK Founded in 2004, Pharmaron is a premier life sciences service provider that offers a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including small molecules, biologics, and CGT products. Pharmaron’s Comprehensive CRO & CDMO Services • Synthetic, Medicinal, and Analytical Chemistry Services • Biology Services (e.g., in vitro screening, structural biology, biomarkers) • DMPK Services (e.g., in vitro ADME, in vivo PK, PKPD, mass balance) • Pharmacology Services (e.g., in vivo pharmacology, animal disease models, immunotoxicity) • Drug Safety Assessment Services (e.g., toxicology, safety pharmacology, genetic toxicology) • Radiochemistry and Isotopically Labelled Metabolism Services (e.g., 14C/Carbon-14 radiosynthesis, 3H/tritium radiosynthesis, QWBA, mARG) • CMC Services (e.g., API manufacturing, process chemistry, formulation development) • Clinical Development Services (e.g., First-in-Human [FIH], ethnobridging, microdosing Phase 0, absolute bioavailability) Commitment to Excellence and Innovation With a proven track record of success, Pharmaron continually invests in its people, facilities, and technologies to meet evolving scientific and regulatory demands. The company prides itself on enabling scientific breakthroughs and supporting its partners in advancing human health. ____________________________________ Learn More: Explore Pharmaron’s services to discover how to accelerate your R&D programs. www.pharmaron.com. ________________________________________ Keywords: CRO, CDMO, synthetic chemistry, medicinal chemistry, biology, radiochemistry, toxicology, First-in-Human, API manufacturing, PKPD, 14C radiosynthesis, discovery biologics, clinical development, small molecules, biologics, cell and gene therapy (CGT) products
- 网站
-
http://www.pharmaron.com
Pharmaron的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Beijing
- 类型
- 私人持股
- 创立
- 2004
- 领域
- Chemistry、Biology、DMPK、Pharmacology、Chemical Development、Preclinical、Toxicology、Safety Pharmacology、Discovery、Lead Optimization、Process Development、Assay Development、ADME、Formulation、clinical pharmacology、analytical sciences、radiolabelled chemistry、accelerator mass spectrometry、radiolabelled compounds、API manufacturing、radiosynthesis、Biologics、CGT 、cell and gene therapy、synthetic chemistry、medicinal chemistry、radiochemistry、PKPD和small molecule
地点
Pharmaron员工
动态
-
Join us on 𝐓𝐮𝐞𝐬𝐝𝐚𝐲, 𝟏𝟏 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟓 𝐚𝐭 𝟖𝐚𝐦 𝐏𝐓 / 𝟏𝟏𝐚𝐦 𝐄𝐓 / 𝟒𝐩𝐦 𝐁𝐒𝐓 for the next edition of Pharmaron’s DMPK webinar series. Explore the foundational and emerging insights into 𝐚𝐥𝐝𝐞𝐡𝐲𝐝𝐞 𝐨𝐱𝐢𝐝𝐚𝐬𝐞 and its role in drug metabolism. This session features a panel of expert scientists. 𝐀𝐭𝐭𝐞𝐧𝐝𝐞𝐞𝐬 𝐰𝐢𝐥𝐥 𝐠𝐚𝐢𝐧 𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨: 🔹General introduction to aldehyde oxidase including cellular and subcellular distribution, catalytic mechanism, endogenous role 🔹Role of aldehyde oxidase in drug metabolism with examples that highlight the structure metabolism relationships for the enzyme 🔹Contribution of aldehyde oxidase metabolism to drug-drug interactions, variability and toxicity 🔹Role of aldehyde oxidase in metabolism of AZD1390 case study 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞: https://lnkd.in/dtp8U7Bm By registering once, you’ll receive access and updates for each webinar in the series. For more information and to watch previous webinars, visit: https://lnkd.in/g5ACuqDp #DMPK #Webinar #DrugMetabolism #PharmaronWebinar
-
-
Ready to dive deep into AAV immunogenicity? Pharmaron’s eBook provides comprehensive insights backed by our 20+ years of experience in the field. Download our eBook today: https://lnkd.in/dP-J2dAs #AAVgenetherapy #AAVimmunogenicity #immunogenicity #Pharmaron #innovation #CGT
-
-
🎉 Join us for an evening of great conversations and even better company at Pharmaron’s Drink Reception during CPHI Frankfurt! 📍 Where: Pharmaron Booth – Hall 6.1 | 6.1B52 🗓️ When: Wednesday, 29 October 2025 ⏰ Time: 17:00 – 20:00 CET 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞: https://lnkd.in/dQ3z9jGx Unwind after a busy day at the expo with refreshing drinks, tasty snacks, and the chance to connect with fellow industry professionals in a relaxed and welcoming atmosphere. Whether you're looking to network, catch up with peers, or simply enjoy a well-earned break — we’d love to see you there! 👉 Save the date and stop by Booth 6.1B52 – we’ll be ready to welcome you! #CPHIFrankfurt #Pharmaron #NetworkingEvent #PharmaCommunity #LifeSciences #CPHI2025
-
-
Day Two at the GMP Symposium – Come Meet Pharmaron! We’re back for day two at the GMP Symposium in Gentilly, France! The Pharmaron team—Severine Marrony, Héloïse Beutier, and Anna Witkowska—is ready to connect and share insights on your drug metabolism programs and our fully integrated ADME services. Find us at booth #3. Whether you're looking to explore collaboration opportunities or simply want to learn more about our capabilities, we’d love to meet you! 📅 Schedule a meeting with our team here: https://lnkd.in/dffN3-Qa #Pharmaron #GMPSymposium #ADME #Metabolism #14C
-
-
Looking to streamline your path to the clinic with fewer handoffs, faster timelines, and scientific continuity? Pharmaron’s Pathfinder is your integrated, end-to-end CMC solution — combining API development, material science and solid-state analysis, pre-formulation, clinical formulation, and GMP manufacturing within one co-located cohesive team. All activities are aligned under a unified analytical and quality framework — ensuring speed, accountability, and seamless execution. 𝐏𝐚𝐭𝐡𝐟𝐢𝐧𝐝𝐞𝐫 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐈𝐧𝐜𝐥𝐮𝐝𝐞: • API Process Development & Manufacturing • Material Science & Pre-formulation • Product Formulation, Analytical Development & Manufacturing • Regulatory Support & Consultation 𝐖𝐡𝐲 𝐏𝐚𝐭𝐡𝐟𝐢𝐧𝐝𝐞𝐫? ✅ Faster timelines through seamless scale-up ✅ Scientific continuity with cross-functional teams ✅ Cost-efficiency by reducing logistics and partner management ➡️ Learn more about Pathfinder: https://lnkd.in/d_E7CQr2 📍 Let’s connect at CPHI Frankfurt! October 28–30, 2025 | Messe Frankfurt | 𝐁𝐨𝐨𝐭𝐡 #𝟔𝟏𝐁𝟓𝟐 – 𝐇𝐚𝐥𝐥 𝟔.𝟏 Schedule a meeting with our team: https://lnkd.in/dqVFTTkQ #Pathfinder #CMC #IntegratedCMC #DrugDevelopment #GMPManufacturing #CPHI2025
-
-
Discover when infusion is the best option for drug dosing in animal studies. To learn more, download our flyer here: https://lnkd.in/dGZD6FvN #Pharmacokinetics #DrugDelivery #DrugDiscovery #DrugDevelopment #Pharmaron
-
At Pharmaron, kinase research isn’t a capability—it’s a cornerstone. With 20+ years of specialized focus, our teams have helped clients advance numerous kinase-targeting compounds into clinical stages. We offer both fee-for-service and fully integrated models, streamlining everything from screening to candidate selection. Why leading innovators choose Pharmaron: ✔️ Unmatched scientific expertise in kinase pathways ✔️ Agile workflows that reduce time-to-decision ✔️ Bespoke solutions for diverse R&D needs Work with a partner that accelerates outcomes without compromising quality. #Pharmaron #kinaseinhibitors #targetdiscovery #biopharma
-
-
Cell-based assays for in vitro testing of protein degrader efficacy require specialized tools and custom-tailored cell lines. Pharmaron has over 8 years of experience in protein degrader discovery and creating all tools required. Our talented cell line engineering tool supports our clients with custom-made cell lines ideally suited for testing new protein degraders. > Generation of dTAG cell lines for target validation > Generation of cell lines with HaloTag-fusion proteins for dynamic degradation tracking > HiBiT assay for real-time POI degradation monitoring > High-content imaging for detailed subcellular location insights > Less automated western /MSD / in-cell western for high-throughput testing of POI degradation > Intracellular target engagement for binary and ternary complexes > E3 or proteasomal dependence mechanistic assays > POI selectivity via TMT labeling mass spectrometry #targetedproteindegradation #drugdiscovery #protac #proteindegradation #TPD #proteindegraders
-
-
Organising a radiolabelled drug development program requires significant forward planning and in-depth scientific expertise in radiosynthetic chemistry, metabolism, and pharmacokinetics (PK). Choosing a strong and experienced partner is essential to ensure success and seamless progression to regulatory drug approval. Pharmaron has a strong track record of supporting our clients' radiolabelled metabolism programs from preclinical to clinical development. For more information, please click here: https://lnkd.in/dFjEmfyn #humanADME #ADME #metabolism #AME #preclinical #clinicalstudies #clinicalresearch #radiosynthesis #radiolabelling #radiolabeling #14c
-